FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2775978739> ?p ?o ?g. }

• W2775978739 endingPage "1460" @default.
• W2775978739 startingPage "1455" @default.
• W2775978739 abstract "BackgroundThe comprehensive stage 2 procedure (CS2) follows initial hybrid stage 1 palliation for patients with single-ventricle physiology. The goal of this study was to describe CS2 outcomes and differences between survivors of CS2 (s-CS2) and nonsurvivors (nons-CS2).MethodAll patients in The Society of Thoracic Surgeons Congenital Heart Surgery Database who underwent CS2 as index operation from 2010 to 2016 were included. Preoperative, operative, and postoperative data were analyzed, stratified by operative mortality (in-hospital or within 30 days of the operation), with univariate comparisons using χ2, Fisher exact, or Wilcoxon rank sum tests.ResultsOf 209 patients (49 centers) who met inclusion criteria, 141 patients had the diagnosis of hypoplastic left heart syndrome. Overall operative mortality was 12.4% (26 of 209). s-CS2 had a lower prevalence of preoperative extracorporeal membrane oxygenation use (0.0% vs 7.7%, p = 0.02) and less frequently underwent concomitant tricuspid valve procedures at the time of the operation (1.1% vs 11.5%, p = 0.01) than nons-CS2. Postoperatively, the prevalence of any of six The Society of Thoracic Surgeons Congenital Heart Surgery Database major complications was higher in nons-CS2 than in s-CS2 (53.9% vs 23.0%, p < 0.01), including a higher prevalence of renal failure (7.7% vs 0.6%, p = 0.04) and postoperative extracorporeal membrane oxygenation use (46.2% vs 2.7%, p < 0.01). There were no other preoperative, operative, or postoperative differences between the two groups.ConclusionsOperative mortality associated with the CS2 procedure is substantial, especially for patients receiving extracorporeal membrane oxygenation support after CS2. No obvious modifiable variables were noted between patients who died and those who survived. The comprehensive stage 2 procedure (CS2) follows initial hybrid stage 1 palliation for patients with single-ventricle physiology. The goal of this study was to describe CS2 outcomes and differences between survivors of CS2 (s-CS2) and nonsurvivors (nons-CS2). All patients in The Society of Thoracic Surgeons Congenital Heart Surgery Database who underwent CS2 as index operation from 2010 to 2016 were included. Preoperative, operative, and postoperative data were analyzed, stratified by operative mortality (in-hospital or within 30 days of the operation), with univariate comparisons using χ2, Fisher exact, or Wilcoxon rank sum tests. Of 209 patients (49 centers) who met inclusion criteria, 141 patients had the diagnosis of hypoplastic left heart syndrome. Overall operative mortality was 12.4% (26 of 209). s-CS2 had a lower prevalence of preoperative extracorporeal membrane oxygenation use (0.0% vs 7.7%, p = 0.02) and less frequently underwent concomitant tricuspid valve procedures at the time of the operation (1.1% vs 11.5%, p = 0.01) than nons-CS2. Postoperatively, the prevalence of any of six The Society of Thoracic Surgeons Congenital Heart Surgery Database major complications was higher in nons-CS2 than in s-CS2 (53.9% vs 23.0%, p < 0.01), including a higher prevalence of renal failure (7.7% vs 0.6%, p = 0.04) and postoperative extracorporeal membrane oxygenation use (46.2% vs 2.7%, p < 0.01). There were no other preoperative, operative, or postoperative differences between the two groups. Operative mortality associated with the CS2 procedure is substantial, especially for patients receiving extracorporeal membrane oxygenation support after CS2. No obvious modifiable variables were noted between patients who died and those who survived." @default.
• W2775978739 created "2018-01-05" @default.
• W2775978739 creator A5013450210 @default.
• W2775978739 creator A5019328016 @default.
• W2775978739 creator A5022478589 @default.
• W2775978739 creator A5032890276 @default.
• W2775978739 creator A5036652425 @default.
• W2775978739 creator A5038127967 @default.
• W2775978739 creator A5044309431 @default.
• W2775978739 creator A5055426845 @default.
• W2775978739 creator A5072878229 @default.
• W2775978739 creator A5081030178 @default.
• W2775978739 date "2018-05-01" @default.
• W2775978739 modified "2023-09-28" @default.
• W2775978739 title "Hybrid Palliation: Outcomes After the Comprehensive Stage 2 Procedure" @default.
• W2775978739 cites W1963925797 @default.
• W2775978739 cites W1970907591 @default.
• W2775978739 cites W1991377869 @default.
• W2775978739 cites W2002385120 @default.
• W2775978739 cites W2007940302 @default.
• W2775978739 cites W2010240922 @default.
• W2775978739 cites W2019569703 @default.
• W2775978739 cites W2024026442 @default.
• W2775978739 cites W2029999128 @default.
• W2775978739 cites W2057253584 @default.
• W2775978739 cites W2057835785 @default.
• W2775978739 cites W2068517007 @default.
• W2775978739 cites W2069197281 @default.
• W2775978739 cites W2069387379 @default.
• W2775978739 cites W2119597704 @default.
• W2775978739 cites W2123250256 @default.
• W2775978739 cites W2132032967 @default.
• W2775978739 cites W2158355896 @default.
• W2775978739 cites W2178899234 @default.
• W2775978739 cites W2219694982 @default.
• W2775978739 cites W2236075926 @default.
• W2775978739 cites W2511876194 @default.
• W2775978739 cites W2548614400 @default.
• W2775978739 cites W2558054794 @default.
• W2775978739 cites W2714692262 @default.
• W2775978739 cites W2755003697 @default.
• W2775978739 cites W2916857260 @default.
• W2775978739 cites W52598778 @default.
• W2775978739 doi "https://doi.org/10.1016/j.athoracsur.2017.11.046" @default.
• W2775978739 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29273201" @default.
• W2775978739 hasPublicationYear "2018" @default.
• W2775978739 type Work @default.
• W2775978739 sameAs 2775978739 @default.
• W2775978739 citedByCount "16" @default.
• W2775978739 countsByYear W27759787392018 @default.
• W2775978739 countsByYear W27759787392019 @default.
• W2775978739 countsByYear W27759787392020 @default.
• W2775978739 countsByYear W27759787392021 @default.
• W2775978739 countsByYear W27759787392023 @default.
• W2775978739 crossrefType "journal-article" @default.
• W2775978739 hasAuthorship W2775978739A5013450210 @default.
• W2775978739 hasAuthorship W2775978739A5019328016 @default.
• W2775978739 hasAuthorship W2775978739A5022478589 @default.
• W2775978739 hasAuthorship W2775978739A5032890276 @default.
• W2775978739 hasAuthorship W2775978739A5036652425 @default.
• W2775978739 hasAuthorship W2775978739A5038127967 @default.
• W2775978739 hasAuthorship W2775978739A5044309431 @default.
• W2775978739 hasAuthorship W2775978739A5055426845 @default.
• W2775978739 hasAuthorship W2775978739A5072878229 @default.
• W2775978739 hasAuthorship W2775978739A5081030178 @default.
• W2775978739 hasBestOaLocation W27759787391 @default.
• W2775978739 hasConcept C120665830 @default.
• W2775978739 hasConcept C121332964 @default.
• W2775978739 hasConcept C126322002 @default.
• W2775978739 hasConcept C141071460 @default.
• W2775978739 hasConcept C144301174 @default.
• W2775978739 hasConcept C146357865 @default.
• W2775978739 hasConcept C151730666 @default.
• W2775978739 hasConcept C164705383 @default.
• W2775978739 hasConcept C2776850375 @default.
• W2775978739 hasConcept C2776858399 @default.
• W2775978739 hasConcept C2778789114 @default.
• W2775978739 hasConcept C2778921608 @default.
• W2775978739 hasConcept C2779384505 @default.
• W2775978739 hasConcept C2779545397 @default.
• W2775978739 hasConcept C2780074459 @default.
• W2775978739 hasConcept C38180746 @default.
• W2775978739 hasConcept C500558357 @default.
• W2775978739 hasConcept C61511704 @default.
• W2775978739 hasConcept C71924100 @default.
• W2775978739 hasConcept C86803240 @default.
• W2775978739 hasConceptScore W2775978739C120665830 @default.
• W2775978739 hasConceptScore W2775978739C121332964 @default.
• W2775978739 hasConceptScore W2775978739C126322002 @default.
• W2775978739 hasConceptScore W2775978739C141071460 @default.
• W2775978739 hasConceptScore W2775978739C144301174 @default.
• W2775978739 hasConceptScore W2775978739C146357865 @default.
• W2775978739 hasConceptScore W2775978739C151730666 @default.
• W2775978739 hasConceptScore W2775978739C164705383 @default.
• W2775978739 hasConceptScore W2775978739C2776850375 @default.
• W2775978739 hasConceptScore W2775978739C2776858399 @default.
• W2775978739 hasConceptScore W2775978739C2778789114 @default.
• W2775978739 hasConceptScore W2775978739C2778921608 @default.

• next